Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS)
Benign prostatic hyperplasia (BPH) is defined histologically. Several terms such as "prostatism", "symptoms of BPH", and "clinical BPH" have previously been used to describe male lower urinary tract symptoms (LUTS). These descriptions incorrectly imply that urinary symptoms in the male arise from the prostate. The acronym "LUTS" was introduced in order to avoid this. Increasingly, scientific communications on this syndrome use the term LUTS and avoid the use of the global term BPH. Nevertheless, BPH remains familiar to and commonly used by general practitioners, other clinicians, and patients when searching for clinical information and guidance. Clinically, the syndrome is characterised by lower urinary tract symptoms (urinary frequency, urgency, a weak and intermittent stream, needing to strain, a sense of incomplete emptying, and nocturia) and can lead to complications, including acute urinary retention.
Management of urinary incontinence in primary care (01 September 2005)
Scottish Intercollegiate Guidelines Network
Finasteride for benign prostatic hyperplasia. ( 25 November 2015 )
Rated by doctors in Relevance Newsworthiness General Practice(GP)/Family Practice(FP) ****** **** General Internal Medicine-Primary Care(US) ****** **** Geriatrics ****** *****
Rated by doctors in Relevance Newsworthiness Surgery - Urology ***** ***